Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease.

Autor: Meng-Ting Wang1 wmt@mail.ndmctsgh.edu.tw, Jyun-Heng Lai1 terry820426@gmail.com, Chen-Liang Tsai2 doc10376@ndmctsgh.edu.tw, Jun-Ting Liou3 ljtmail@gmail.com
Zdroj: Journal of Food & Drug Analysis. Jul2019, Vol. 27 Issue 3, p657-670. 14p.
Databáze: Academic Search Ultimate